BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17974954)

  • 1. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation.
    Zhu S; Bjorge JD; Fujita DJ
    Cancer Res; 2007 Nov; 67(21):10129-37. PubMed ID: 17974954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
    Zhu S; Bjorge JD; Cheng HC; Fujita DJ
    Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer.
    Liu H; Wu Y; Zhu S; Liang W; Wang Z; Wang Y; Lv T; Yao Y; Yuan D; Song Y
    Cancer Lett; 2015 Apr; 359(2):218-25. PubMed ID: 25617799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
    Staley CA; Parikh NU; Gallick GE
    Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Yes tyrosine kinase activity in human colon carcinoma.
    Park J; Meisler AI; Cartwright CA
    Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.
    Subramaniam V; Vincent IR; Gardner H; Chan E; Dhamko H; Jothy S
    Exp Mol Pathol; 2007 Oct; 83(2):207-15. PubMed ID: 17599831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.
    Leroy C; Fialin C; Sirvent A; Simon V; Urbach S; Poncet J; Robert B; Jouin P; Roche S
    Cancer Res; 2009 Mar; 69(6):2279-86. PubMed ID: 19276381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src kinase regulation by phosphorylation and dephosphorylation.
    Roskoski R
    Biochem Biophys Res Commun; 2005 May; 331(1):1-14. PubMed ID: 15845350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
    Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
    Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation.
    Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A
    Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells.
    Huang RY; Wen CC; Liao CK; Wang SH; Chou LY; Wu JC
    Cell Biol Int; 2012 Sep; 36(9):833-41. PubMed ID: 22582758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of src-related tyrosine kinases by IL-3.
    Anderson SM; Jorgensen B
    J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
    Brunton VG; Ozanne BW; Paraskeva C; Frame MC
    Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.
    Irby RB; Yeatman TJ
    Cancer Res; 2002 May; 62(9):2669-74. PubMed ID: 11980666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.